Elevated Plasma Tissue-type Plasminogen Activator (t-PA) and Soluble Throm- bomodulin in Patients Suffering From Severe Acute Respiratory Syndrome (SARS) as a Possible Index for Prognosis and Treatment Strategy1
نویسندگان
چکیده
School of Medicine, Xi’an Jiaotong University (SMXJU), Xi’an 710061, Shaanxi, China; Basic Medical Science Institute, Taishan Medical College (TMC), Tai’an, China; Haematology, University Medical Center Utrecht (UMCU), the Netherlands; Xuanwu Hospital of Capital University of Medical Sciences, Beijing, China; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China; § College of Medicine, Shandong University, Jinan, China
منابع مشابه
A clinical study investigating the three months prognosis of patients with ischemic stroke treated with recombinant tissue plasminogen activator (rt-PA) and its effective factors
Objective: Currently, treating ischemic stroke by intravenous thrombolytic therapy has acceptable results in patients with stroke. This study aimed to evaluate the three months prognosis of patients treated with recombinant tissue plasminogen activator (rt-PA).Methods: This cross-sectional prospective study was conducted on 30 patients with cerebral ischemic stroke with the National Insti...
متن کاملHematology findings in patients with Coronavirus disease 2019 (COVID-19)
In December 2019, Wuhan, the capital of Hubei Province in China, became the center of an outbreak of pneumonia with unknown etiology. By 7 January 2020, Chinese scientists have isolated a new coronavirus from patients with viral infectious pneumonia, the Coronavirus 2 Acute Respiratory Syndrome (SARS-CoV-2), previously called 2019-nCoV. The disease was later diagnosed as coronavirus 2019 (COVID...
متن کاملNeutrophils to Lymphocytes Ratio and the Prognosisof the COVID-19 Patients
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new pandemic virus, a global concern, and has threatened human health. This virus binds to the Angiotensin-Converting Enzyme 2 (ACE2) that is expressed on different cells, especially on the alveolar cells. So the virus can enter the lung cells and causes respiratory syndromes. In Coronavirus Disease 2019 (COVID-19) that is cause...
متن کاملSoluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
Background: The biomarker soluble urokinase plasminogen activator receptor (suPAR) is an indicator of inflammation which is increased in a variety of chronic and acute disease states. Its most promising application in the emergency setting is to aid in the prognostic stratification of patients by identifying those at high risk of deterioration. This is a narrative review of studies evaluating t...
متن کاملA Review of the Possible Effects of Curcumin in the Treatment of COVID-19
COVID-19, which is caused by the SARS-Cov-2, begins with early symptoms of fever, cough, shortness of breath, myalgia, and fatigue, affecting the lungs with pneumonia and causing acute respiratory distress syndrome (ARDS). Also, the onset of the disease may with rapid progression, lead to organ dysfunction, such as acute kidney or liver damage, and even death in severe cases. Many scientific ef...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2006